Cargando…
The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 pati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131433/ https://www.ncbi.nlm.nih.gov/pubmed/37101303 http://dx.doi.org/10.1186/s13023-023-02704-7 |
_version_ | 1785031176734375936 |
---|---|
author | Lee, Yuna Lee, Seunghyun Hur, Saebeom Jeong, Yun Soo Suh, Dong In Moon, Jangsup Kim, Man Jin Choi, Young Hun Cheon, Jung-Eun |
author_facet | Lee, Yuna Lee, Seunghyun Hur, Saebeom Jeong, Yun Soo Suh, Dong In Moon, Jangsup Kim, Man Jin Choi, Young Hun Cheon, Jung-Eun |
author_sort | Lee, Yuna |
collection | PubMed |
description | BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 patients with GSD between January 2001 and December 2020. After December 2018, DCMRL examinations were performed for lymphatic vessel evaluation in patients with GSD and reviewed in four patients. RESULTS: The median age at diagnosis was 9 years (range: 2 months–53 years). The clinical manifestations were dyspnea in seven patients (46.7%), sepsis in 12 (80.0%), orthopedic problems in seven (46.7%), and bloody chylothorax in seven (46.7%). The common sites of osseous involvement were the spine (73.3%) and pelvic bone (60.0%). Among the non-osseous involvements, peri-osseous infiltrative soft-tissue abnormalities adjacent to the area of bone involvement were the most common (86.7%), followed by splenic cysts (26.7%) and interstitial thickening (26.7%). DCMRL demonstrated weak central conducting lymphatic flow in two patients with abnormal giant tortuous thoracic ducts and no flow in one patient. All patients who underwent DCMRL in this study presented with altered anatomical lymphatics and functional flow with collateralization. CONCLUSION: DCMRL imaging and plain radiography are very useful for determining the extent of GSD. DCMRL is a novel imaging tool for the visualization of abnormal lymphatics in patients with GSD, which helps in further treatment. Therefore, in patients with GSD, it might be necessary to obtain not only plain radiographs but also MR and DCMRL images. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02704-7. |
format | Online Article Text |
id | pubmed-10131433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101314332023-04-27 The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography Lee, Yuna Lee, Seunghyun Hur, Saebeom Jeong, Yun Soo Suh, Dong In Moon, Jangsup Kim, Man Jin Choi, Young Hun Cheon, Jung-Eun Orphanet J Rare Dis Research BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 patients with GSD between January 2001 and December 2020. After December 2018, DCMRL examinations were performed for lymphatic vessel evaluation in patients with GSD and reviewed in four patients. RESULTS: The median age at diagnosis was 9 years (range: 2 months–53 years). The clinical manifestations were dyspnea in seven patients (46.7%), sepsis in 12 (80.0%), orthopedic problems in seven (46.7%), and bloody chylothorax in seven (46.7%). The common sites of osseous involvement were the spine (73.3%) and pelvic bone (60.0%). Among the non-osseous involvements, peri-osseous infiltrative soft-tissue abnormalities adjacent to the area of bone involvement were the most common (86.7%), followed by splenic cysts (26.7%) and interstitial thickening (26.7%). DCMRL demonstrated weak central conducting lymphatic flow in two patients with abnormal giant tortuous thoracic ducts and no flow in one patient. All patients who underwent DCMRL in this study presented with altered anatomical lymphatics and functional flow with collateralization. CONCLUSION: DCMRL imaging and plain radiography are very useful for determining the extent of GSD. DCMRL is a novel imaging tool for the visualization of abnormal lymphatics in patients with GSD, which helps in further treatment. Therefore, in patients with GSD, it might be necessary to obtain not only plain radiographs but also MR and DCMRL images. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02704-7. BioMed Central 2023-04-26 /pmc/articles/PMC10131433/ /pubmed/37101303 http://dx.doi.org/10.1186/s13023-023-02704-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lee, Yuna Lee, Seunghyun Hur, Saebeom Jeong, Yun Soo Suh, Dong In Moon, Jangsup Kim, Man Jin Choi, Young Hun Cheon, Jung-Eun The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title | The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title_full | The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title_fullStr | The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title_full_unstemmed | The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title_short | The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography |
title_sort | spectrum of imaging manifestations of gorham–stout disease: a novel dynamic contrast-enhanced mr lymphangiography |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131433/ https://www.ncbi.nlm.nih.gov/pubmed/37101303 http://dx.doi.org/10.1186/s13023-023-02704-7 |
work_keys_str_mv | AT leeyuna thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT leeseunghyun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT hursaebeom thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT jeongyunsoo thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT suhdongin thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT moonjangsup thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT kimmanjin thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT choiyounghun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT cheonjungeun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT leeyuna spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT leeseunghyun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT hursaebeom spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT jeongyunsoo spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT suhdongin spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT moonjangsup spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT kimmanjin spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT choiyounghun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography AT cheonjungeun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography |